Vote for BJP in urban local bodies" poll for "triple engine" govt in UP: Adityanath

UP: Man booked for attempting to rape 5-year-old girl

Congress to mark 100 days of Bharat Jodo Yatra with concert in Jaipur

BJYM, Hindu outfits put off planned protest march at AMU

Karachi battles gas crisis; residents face unannounced load shedding, 2-hr gas supply in a day

Elderly man in judicial custody dies during treatment in UP hospital

Himachal Pradesh skittle Haryana for 46, take 200-run lead on Day 1

Pak court grants protective bail to PM Shehbaz"s son Suleman in money laundering case

British Library celebrates India ties with exhibition on Hampi

Nine policemen suspended after suspect dies in police custody in UP

Gangster"s property attached in UP"s Pratapgarh district

Maoists torch construction company vehicles in Jharkhand’s Chatra district

Sino-India border situation "generally stable": China on Yangtse clash

Babar Azam not taking advice from seniors, claims Shahid Afridi

Qlite Global launches their exclusive Grand Experience Centre

"Disillusioned with central leadership": Sikkim BJP president says he has resigned

2001 attack anniversary: Ready to guard new Parliament if directed, say CRPF heroes

Class 2 student dies after scuffle with fellow students in UP

Three killed in accident in UP"s Lakhimpur KheriLakhimpur Kheri (UP), Dec 13 (PTI) Three motorcycle borne youths were killed and "

Abandoned girl child from Assam adopted by Spanish professor

Home >> Delhi

HC quashes Centre’s ban on oxytocin drug production, sale

| Friday | 14th December, 2018

New Delhi: The Delhi High Court on Friday set aside a Central Government order restraining private companies from manufacturing and selling oxytocin drug. The court also observed that oxytocin was an essential life saving drug. The State-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed to produce the drug for domestic use. Earlier this year, the government had restricted the manufacture of oxytocin formulations for domestic use to public sector only. Chawla observed that the order was “unreasonable and arbitrary” and did not seem to be based on any scientific study.

New Delhi: The Delhi High Court on Friday set aside a Central Government order restraining private companies from manufacturing and selling oxytocin drug. A Bench of Justices S. Ravindra Bhat and A.K. Chawla observed that the order was “unreasonable and arbitrary” and did not seem to be based on any scientific study. The court also observed that oxytocin was an essential life saving drug. The court heard the pleas of Mylan Laboratories’ subsidiary BGP Products Operations GmbH, Neon Laboratories and the All India Drug Action Network (AIDAN), an NGO, challenging the government decision. Earlier this year, the government had restricted the manufacture of oxytocin formulations for domestic use to public sector only. The State-run Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL) was solely allowed to produce the drug for domestic use. The decision taken under Section 26A of the Drugs and Cosmetics Act, 1940 is aimed at checking the misuse of oxytocin, a reproductive hormone found in mammals that increases the contraction of the uterus during labour and stimulates ejection of milk into the ducts of the breasts. Source: IANS

If You Like This Story, Support NYOOOZ

NYOOOZ SUPPORTER

₹ 10 - ₹ 1000

NYOOOZ FRIEND

₹ 2000 - ₹ 5000

Your support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream media organizations.

Stay updated with all the Delhi Latest News headlines here. For more exclusive & live news updates from all around India, stay connected with NYOOOZ.